0
Eiger BioPharmaceuticals, Inc.  Banner Image

Eiger BioPharmaceuticals, Inc. has reached its limit for free report views

Work for Eiger BioPharmaceuticals, Inc. ? Upgrade Your Profile and unlock all your annual reports.

Eiger BioPharmaceuticals, Inc.

  • Ticker EIGR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eiger BioPharmaceuticals, Inc.  Logo Image
  • 11-50 Employees
  • Based in Palo Alto, California
Eiger is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. Eiger's pipeline includes preclinical NCEs from discovery as well repurposed clinical Rx agents shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. http://www.eigerbio.com
Eiger BioPharmaceuticals, Inc.

Most Recent Annual Report

Eiger BioPharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Eiger BioPharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports